These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33839229)

  • 41. FDA, companies test RFID tracking to prevent drug counterfeiting.
    James JS
    AIDS Treat News; 2005 Dec; (417):5-8. PubMed ID: 16541509
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Emerging nanotechnology role in the development of innovative solutions against COVID-19 pandemic.
    Bhutta ZA; Kanwal A; Ali M; Kulyar MF; Yao W; Shoaib M; Ashar A; Mahfooz A; Ijaz M; Ijaz N; Asif M; Nawaz S; Mahfooz MR; Kanwal T
    Nanotechnology; 2021 Sep; 32(48):. PubMed ID: 34320471
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Straight talk with...Aline Plançon. Interview by Asher Mullard.
    Plançon A
    Nat Med; 2010 Apr; 16(4):365. PubMed ID: 20376035
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Poor-Quality and Counterfeit Drugs: A Systematic Assessment of Prevalence and Risks Based on Data Published From 2007 to 2016.
    Koczwara A; Dressman J
    J Pharm Sci; 2017 Oct; 106(10):2921-2929. PubMed ID: 28549909
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nanotechnology Responses to COVID-19.
    Ruiz-Hitzky E; Darder M; Wicklein B; Ruiz-Garcia C; Martín-Sampedro R; Del Real G; Aranda P
    Adv Healthc Mater; 2020 Oct; 9(19):e2000979. PubMed ID: 32885616
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Designing lanthanide-doped nanocrystals with both up- and down-conversion luminescence for anti-counterfeiting.
    Liu Y; Ai K; Lu L
    Nanoscale; 2011 Nov; 3(11):4804-10. PubMed ID: 21993996
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bioinspired Quasi-3D Multiplexed Anti-Counterfeit Imaging via Self-Assembled and Nanoimprinted Photonic Architectures.
    Lai X; Ren Q; Vogelbacher F; Sha WEI; Hou X; Yao X; Song Y; Li M
    Adv Mater; 2022 Jan; 34(3):e2107243. PubMed ID: 34731906
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Challenge of Counterfeit Drugs: A Comprehensive Review on Prevalence, Detection and Preventive Measures.
    Kumar B; Baldi A
    Curr Drug Saf; 2016; 11(2):112-20. PubMed ID: 26463250
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Counterfeiting of drugs in Brazil.
    Ames J; Souza DZ
    Rev Saude Publica; 2012 Feb; 46(1):154-9. PubMed ID: 22218762
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Microtaggant Technology for Ensuring Traceability of Pharmaceutical Formulations: Potential for Anti-counterfeiting Measures, Distribution and Medication Management].
    Yasunaga T; Fukuoka T; Yamaguchi A; Ogawa N; Yamamoto H
    Yakugaku Zasshi; 2022; 142(11):1255-1265. PubMed ID: 36328452
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nanotechnology Enabled Solutions to Combat Covid-19: Prevention, Treatment, and Diagnosis.
    Musyuni P; Nagpal M; Singh M; Goyal RK; Aggarwal G
    Curr Pharm Biotechnol; 2022; 23(1):98-111. PubMed ID: 33480338
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recent advances in the capillary electrophoresis analysis of antibiotics with capacitively coupled contactless conductivity detection.
    Paul P; Sänger-van de Griend C; Adams E; Van Schepdael A
    J Pharm Biomed Anal; 2018 Sep; 158():405-415. PubMed ID: 29940496
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Three-dimensional quick response code based on inkjet printing of upconversion fluorescent nanoparticles for drug anti-counterfeiting.
    You M; Lin M; Wang S; Wang X; Zhang G; Hong Y; Dong Y; Jin G; Xu F
    Nanoscale; 2016 May; 8(19):10096-104. PubMed ID: 27119377
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Update on counterfeit antibiotics worldwide; public health risks.
    Delepierre A; Gayot A; Carpentier A
    Med Mal Infect; 2012 Jun; 42(6):247-55. PubMed ID: 22621827
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Carbon Dot Fluorescence-Lifetime-Encoded Anti-Counterfeiting.
    Kalytchuk S; Wang Y; Poláková K; Zbořil R
    ACS Appl Mater Interfaces; 2018 Sep; 10(35):29902-29908. PubMed ID: 30085654
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pathogens and Global Health counterfeit medicine photo campaign.
    Pathog Glob Health; 2012 May; 106(2):72. PubMed ID: 22943538
    [No Abstract]   [Full Text] [Related]  

  • 58. A high security coding and anti-counterfeiting method based on the nonlinear magnetization response of superparamagnetic nanomaterials.
    Bai S; Lin Y; Wang X; Zhang X; Yoshida T; Yue X
    Sci Rep; 2024 Jul; 14(1):15360. PubMed ID: 38965281
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A review of radio frequency identification technology for the anatomic pathology or biorepository laboratory: Much promise, some progress, and more work needed.
    Lou JJ; Andrechak G; Riben M; Yong WH
    J Pathol Inform; 2011; 2():34. PubMed ID: 21886890
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Counterfeit phosphodiesterase type 5 inhibitors--growing safety risks for public health].
    Fijałek Z; Sarna K; Błazewicz A; Marin J
    Rocz Panstw Zakl Hig; 2010; 61(3):227-35. PubMed ID: 21365856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.